View Course Material
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Investigating the Oligomerization of Vitronectin
University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Masters Theses Graduate School 12-2008 Investigating the Oligomerization of Vitronectin Yacynth Ruwansara University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes Part of the Biology Commons Recommended Citation Ruwansara, Yacynth, "Investigating the Oligomerization of Vitronectin. " Master's Thesis, University of Tennessee, 2008. https://trace.tennessee.edu/utk_gradthes/483 This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a thesis written by Yacynth Ruwansara entitled "Investigating the Oligomerization of Vitronectin." I have examined the final electronic copy of this thesis for form and content and recommend that it be accepted in partial fulfillment of the equirr ements for the degree of Master of Science, with a major in Biochemistry and Cellular and Molecular Biology. Cynthia Peterson, Major Professor We have read this thesis and recommend its acceptance: Dan Roberts, Liz Howell Accepted for the Council: Carolyn R. Hodges Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) To the Graduate Council: I am submitting herewith a thesis written by Yacynth Ruwansara entitled “Investigating the Oligomerization of Vitronectin.” I have examined the final electronic copy of this thesis for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Master of Science, with a major in Biochemistry, Cellular and Molecular Biology. -
The Urokinase Receptor: a Multifunctional Receptor in Cancer Cell Biology
International Journal of Molecular Sciences Review The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications Anna Li Santi 1,†, Filomena Napolitano 2,†, Nunzia Montuori 2 and Pia Ragno 1,* 1 Department of Chemistry and Biology, University of Salerno, Fisciano, 84084 Salerno, Italy; [email protected] 2 Department of Translational Medical Sciences, “Federico II” University, 80135 Naples, Italy; fi[email protected] (F.N.); [email protected] (N.M.) * Correspondence: [email protected] † Equal contribution. Abstract: Proteolysis is a key event in several biological processes; proteolysis must be tightly con- trolled because its improper activation leads to dramatic consequences. Deregulation of proteolytic activity characterizes many pathological conditions, including cancer. The plasminogen activation (PA) system plays a key role in cancer; it includes the serine-protease urokinase-type plasminogen activator (uPA). uPA binds to a specific cellular receptor (uPAR), which concentrates proteolytic activity at the cell surface, thus supporting cell migration. However, a large body of evidence clearly showed uPAR involvement in the biology of cancer cell independently of the proteolytic activity of its ligand. In this review we will first describe this multifunctional molecule and then we will discuss how uPAR can sustain most of cancer hallmarks, which represent the biological capabilities acquired during the multistep cancer development. Finally, we will illustrate the main data available in the literature on uPAR as a cancer biomarker and a molecular target in anti-cancer therapy. Citation: Li Santi, A.; Napolitano, F.; Montuori, N.; Ragno, P. The Keywords: urokinase receptor; uPAR; cancer hallmarks Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. -
Crystal Structure of Enpp1, an Extracellular Glycoprotein Involved in Bone Mineralization and Insulin Signaling
Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling Kazuki Katoa,1, Hiroshi Nishimasua,1, Shinichi Okudairab, Emiko Miharac, Ryuichiro Ishitania, Junichi Takagic,2, Junken Aokib,2, and Osamu Nurekia,2 aDepartment of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan; bGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan; and cInstitute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan Edited by Paul Schimmel, The Skaggs Institute for Chemical Biology, La Jolla, CA, and approved September 6, 2012 (received for review May 12, 2012) Enpp1 is a membrane-bound glycoprotein that regulates bone as “K121Q,” assuming the use of the ATG start codon 156 bp mineralization by hydrolyzing extracellular nucleotide triphosphates downstream from the correct one) is associated with insulin re- to produce pyrophosphate. Enpp1 dysfunction causes human dis- sistance, type 2 diabetes, and obesity (15, 16). eases characterized by ectopic calcification. Enpp1 also inhibits insulin Enpp1 is implicated in a variety of physiological and pathological signaling, and an Enpp1 polymorphism is associated with insulin conditions. However, the precise mechanisms by which Enpp1 resistance. However, the precise mechanism by which Enpp1 func- participates in these cellular processes remain unclarified because tions in these cellular processes remains elusive. Here, we report the of the lack of structural information. Although Enpp1 is essential crystal structures of the extracellular region of mouse Enpp1 in for the regulation of physiological mineralization, its substrate complex with four different nucleotide monophosphates, at resolu- specificity for different nucleotides and the molecular mechanism tions of 2.7–3.2 Å. -
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: to Target Or Not to Target?
International Journal of Molecular Sciences Review A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? Machteld Sillen and Paul J. Declerck * Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, B-3000 Leuven, Belgium; [email protected] * Correspondence: [email protected] Abstract: Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of plasminogen activators (PAs) and is therefore an important inhibitor of the plasminogen/plasmin system. Being the fast-acting inhibitor of tissue-type PA (tPA), PAI-1 primarily attenuates fibrinolysis. Through inhibition of urokinase-type PA (uPA) and interaction with biological ligands such as vitronectin and cell-surface receptors, the function of PAI-1 extends to pericellular proteolysis, tissue remodeling and other processes including cell migration. This review aims at providing a general overview of the properties of PAI-1 and the role it plays in many biological processes and touches upon the possible use of PAI-1 inhibitors as therapeutics. Keywords: plasminogen activator inhibitor-1; PAI-1; fibrinolysis; cardiovascular disease; cancer; inflammation; fibrosis; aging Citation: Sillen, M.; Declerck, P.J. 1. Introduction A Narrative Review on Plasminogen Plasminogen activator inhibitor-1 (PAI-1) belongs to the family of serine protease Activator Inhibitor-1 and Its inhibitors (serpins) and is an important regulator of the plasminogen/plasmin system (Patho)Physiological Role: To Target (Figure1)[ 1]. This system revolves around the conversion of the zymogen plasmino- or Not to Target?. Int. J. Mol. Sci. 2021, gen into the active enzyme plasmin through proteolytic cleavage that is mediated by 22, 2721. -
Molecular Cloning of S-Protein, a Link Between Complement, Coagulation and Cell-Substrate Adhesion
The EMBO Journal vol.4 no.12 pp.3153-3157, 1985 Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion Dieter Jenne' and Keith K.Stanley2 bystander cells against lysis by fluid phase C5b-7 and the inhibi- lInstitute of Medical Microbiology, Justus-Liebig-University in Giessen, tion of C9 polymerisation during fluid phase assembly. Schubertstrasse 1, 6300 Giessen, and 2European Molecular Biology S-protein may also have a physiological role in the coagulation Laboratory, Meyerhofstrasse 1, Postfach 10.2209, 6900 Heidelberg, FRG pathway since S-protein can be observed in a complex with Communicated by R.Cortese thrombin in serum (after coagulation), but not in plasma (Podack and Muller-Eberhard, 1979). This complex has been shown to cDNA clones coding for human S-protein have been isolated be a stable trimolecular complex containing antithrombin HI in using monoclonal antibodies to screen a cDNA library in pEX. addition (Jenne et al., 1985a). S-protein can modulate the ac- These clones are shown to be authentic S-protein clones on tivity of thrombin by annulling the heparin-dependent activation the basis of sequence, composition and immunological criteria. ofthe thrombin inhibitor, antithrombin Il (Preissner et al., 1985), The complete open reading frame sequence for S-protein has and by a direct reduction of antithrombin IH inhibition of throm- been determined and shows it to be a single polypeptide chain bin (Jenne et al., 1985a). of 459 amino acids preceded by a cleaved leader peptide of Here we report the molecular cloning and cDNA sequence of 19 residues. -
The Biocyc Collection of Microbial Genomes and Metabolic Pathways Peter D
Briefings in Bioinformatics, 2017, 1–9 doi: 10.1093/bib/bbx085 Paper Downloaded from https://academic.oup.com/bib/advance-article-abstract/doi/10.1093/bib/bbx085/4084231 by guest on 02 May 2019 The BioCyc collection of microbial genomes and metabolic pathways Peter D. Karp, Richard Billington, Ron Caspi, Carol A. Fulcher, Mario Latendresse, Anamika Kothari, Ingrid M. Keseler, Markus Krummenacker, Peter E. Midford, Quang Ong, Wai Kit Ong, Suzanne M. Paley and Pallavi Subhraveti Corresponding author: Peter D. Karp, Bioinformatics Research Group, SRI International, 333 Ravenswood Ave, AE206, Menlo Park, CA 94025, USA. E-mail: [email protected] Abstract BioCyc.org is a microbial genome Web portal that combines thousands of genomes with additional information inferred by computer programs, imported from other databases and curated from the biomedical literature by biologist curators. BioCyc also provides an extensive range of query tools, visualization services and analysis software. Recent advances in BioCyc in- clude an expansion in the content of BioCyc in terms of both the number of genomes and the types of information available for each genome; an expansion in the amount of curated content within BioCyc; and new developments in the BioCyc soft- ware tools including redesigned gene/protein pages and metabolite pages; new search tools; a new sequence-alignment tool; a new tool for visualizing groups of related metabolic pathways; and a facility called SmartTables, which enables biolo- gists to perform analyses that previously would have required a programmer’s assistance. Key words: genome databases; microbial genome databases; metabolic pathway databases Peter Karp is the Director of the SRI Bioinformatics Research Group (BRG). -
Biological Capacities Clearly Define a Major Subdivision in Domain Bacteria 4 5 Raphaël Méheust+,1,2, David Burstein+,1,3,8, Cindy J
bioRxiv preprint doi: https://doi.org/10.1101/335083; this version posted May 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Research article 2 3 Biological capacities clearly define a major subdivision in Domain Bacteria 4 5 Raphaël Méheust+,1,2, David Burstein+,1,3,8, Cindy J. Castelle1,2,4 and Jillian F. Banfield1,2,4,5,6,7,*,# 6 7 1Department of Earth and Planetary Science, University of California, Berkeley, Berkeley, CA, USA 8 2Innovative Genomics Institute, Berkeley, CA, USA 9 3 California Institute for Quantitative Biosciences (QB3), University of California Berkeley, CA USA 10 4Chan Zuckerberg Biohub, San Francisco, CA, USA 11 5University of Melbourne, Melbourne, VIC, Australia 12 6Lawrence Berkeley National Laboratory, Berkeley, CA, USA 13 7Department of Environmental Science, Policy and Management, University of California, Berkeley, 14 Berkeley, CA, USA 15 8Present address: School of Molecular and Cell Biology and Biotechnology, George S. Wise Faculty of 16 Life Sciences, Tel Aviv University, Tel Aviv, Israel 17 +These authors contributed equally to this work 18 *Correspondence: [email protected] 19 #Lead Contact 20 21 Resume 22 Phylogenetic analyses separate candidate phyla radiation (CPR) bacteria from other bacteria, but 23 the degree to which their proteomes are distinct remains unclear. Here, we leveraged a proteome 24 database that includes sequences from thousands of uncultivated organisms to identify protein 25 families and examine their organismal distributions. We focused on widely distributed protein 26 families that co-occur in genomes, as they likely foundational for metabolism. -
Hundreds of Novel Composite Genes and Chimeric Genes with Bacterial
Hundreds of novel composite genes and chimeric genes with bacterial origins contributed to haloarchaeal evolution Raphaël Méheust, Andrew Watson, Francois-Joseph Lapointe, R. Thane Papke, Philippe Lopez, Eric Bapteste To cite this version: Raphaël Méheust, Andrew Watson, Francois-Joseph Lapointe, R. Thane Papke, Philippe Lopez, et al.. Hundreds of novel composite genes and chimeric genes with bacterial origins contributed to haloarchaeal evolution. Genome Biology, BioMed Central, 2018, 19, pp.75. 10.1186/s13059-018- 1454-9. hal-01830047 HAL Id: hal-01830047 https://hal.sorbonne-universite.fr/hal-01830047 Submitted on 4 Jul 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Méheust et al. Genome Biology (2018) 19:75 https://doi.org/10.1186/s13059-018-1454-9 RESEARCH Open Access Hundreds of novel composite genes and chimeric genes with bacterial origins contributed to haloarchaeal evolution Raphaël Méheust1, Andrew K. Watson1, François-Joseph Lapointe3, R. Thane Papke2, Philippe Lopez1 and Eric Bapteste1* Abstract Background: Haloarchaea, a major group of archaea, are able to metabolize sugars and to live in oxygenated salty environments. Their physiology and lifestyle strongly contrast with that of their archaeal ancestors. -
Allosteric Disulfide Bonds in Thrombosis and Thrombolysis
Journal of Thrombosis and Haemostasis, 4: 2533–2541 REVIEW ARTICLE Allosteric disulfide bonds in thrombosis and thrombolysis V . M . C H E N * and P . J . H O G G * *Centre for Vascular Research, University of New South Wales, Sydney; and Children’s Cancer Institute Australia for Medical Research, Sydney, Australia To cite this article: Chen VM, Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 2006; 4: 2533–41. most frequently acquired amino acid in eight of the 15 taxa Summary. Allosteric disulfide bonds control protein function studied. Other amino acids that have accrued are Met, His, Ser by mediating conformational change when they undergo and Phe, whereas Pro, Ala, Glu and Gly have been lost. reduction or oxidation. The known allosteric disulfide bonds Considering that disulfide bonds follow addition of Cys, this are characterized by a particular bond geometry, the )RHSta- analysis indicates that acquisition of these bonds is a relatively ple. A number of thrombosis and thrombolysis proteins contain recent evolutionary event. one or more disulfide bonds of this type. Tissue factor (TF) was the first hemostasis protein shown to be controlled by an Types and classification of disulfide bonds allosteric disulfide bond, the Cys186–Cys209 bond in the membrane-proximal fibronectin type III domain. TF exists in There are two general types of disulfide bond; structural and three forms on the cell surface: a cryptic form that is inert, a functional. The structural bonds, which are the majority, are coagulant form that rapidly binds factor VIIa to initiate involved in the folding of a protein and stabilize the tertiary coagulation, and a signaling form that binds FVIIa and cleaves structure. -
Psortm: a Bacterial and Archaeal Protein Subcellular Localization Prediction Tool for Metagenomics Data Michael A
Bioinformatics, 36(10), 2020, 3043–3048 doi: 10.1093/bioinformatics/btaa136 Advance Access Publication Date: 28 February 2020 Original Paper Sequence analysis PSORTm: a bacterial and archaeal protein subcellular localization prediction tool for metagenomics data Michael A. Peabody1,†, Wing Yin Venus Lau1,†, Gemma R. Hoad1,2, Baofeng Jia1, Finlay Maguire3, Kristen L. Gray1, Robert G. Beiko3 and Fiona S. L. Brinkman1,* 1Department of Molecular Biology and Biochemistry, 2Research Computing Group, Simon Fraser University, Burnaby, BC V5A 1S6, Canada and 3Department of Computer Science, Dalhousie University, Halifax, NS B3H 4R2, Canada *To whom correspondence should be addressed. †The authors wish it to be known that these authors contributed equally. Associate Editor: Yann Ponty Received on July 3, 2019; revised on January 23, 2020; editorial decision on February 19, 2020; accepted on February 25, 2020 Abstract Motivation: Many methods for microbial protein subcellular localization (SCL) prediction exist; however, none is readily available for analysis of metagenomic sequence data, despite growing interest from researchers studying microbial communities in humans, agri-food relevant organisms and in other environments (e.g. for identification of cell-surface biomarkers for rapid protein-based diagnostic tests). We wished to also identify new markers of water quality from freshwater samples collected from pristine versus pollution-impacted watersheds. Results: We report PSORTm, the first bioinformatics tool designed for prediction of diverse bacterial and archaeal protein SCL from metagenomics data. PSORTm incorporates components of PSORTb, one of the most precise and widely used protein SCL predictors, with an automated classification by cell envelope. An evaluation using 5-fold cross-validation with in silico-fragmented sequences with known localization showed that PSORTm maintains PSORTb’s high precision, while sensitivity increases proportionately with metagenomic sequence fragment length. -
Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Structure Article Structure of NPP1, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Involved in Tissue Calcification Silvia Jansen,1,6 Anastassis Perrakis,4,6,* Chris Ulens,2 Claudia Winkler,1 Maria Andries,1 Robbie P. Joosten,4 Maarten Van Acker,1 Frank P. Luyten,3 Wouter H. Moolenaar,5 and Mathieu Bollen1,* 1Laboratory of Biosignaling and Therapeutics, Department of Cellular and Molecular Medicine 2Laboratory of Structural Neurobiology, Department of Cellular and Molecular Medicine 3Laboratory for Skeletal Development and Joint Disorders University of Leuven, 3000 Leuven, Belgium 4Division of Biochemistry 5Division of Cell Biology The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 6These authors contributed equally to this work *Correspondence: [email protected] (A.P.), [email protected] (M.B.) http://dx.doi.org/10.1016/j.str.2012.09.001 SUMMARY NPP2, also known as autotaxin (ATX), are the best-characterized NPP family members. NPP1 is a glycoprotein that forms Ectonucleotide pyrophosphatase/phosphodiester- disulfide-bonded homodimers in the plasma membrane and ase-1 (NPP1) converts extracellular nucleotides into mineral-depositing matrix vesicles of osteoblasts and chondro- inorganic pyrophosphate, whereas its close rela- cytes (Johnson et al., 1999, 2001; Terkeltaub, 2006; Vaingankar tive NPP2/autotaxin hydrolyzes lysophospholipids. et al., 2004). NPP1 hydrolyzes extracellular nucleotides into NPP1 regulates calcification in mineralization- inorganic pyrophosphate (PPi), a potent inhibitor of hydroxyapa- competent tissues, and a lack of NPP1 function un- tite (HA) crystal formation in mineralization-competent tissues (Terkeltaub, 2001). NPP2/ATX is a secreted lysophospholipase derlies calcification disorders. -
Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action
Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action Allison A. Eddy* and Agnes B. Fogo† *Children’s Hospital and Regional Medical Center, Department of Pediatrics, University of Washington, Seattle, Washington; and †Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee J Am Soc Nephrol 17: 2999–3012, 2006. doi: 10.1681/ASN.2006050503 n 1984, Loskutoff et al. (1) purified plasminogen activator PAI-1 Is Present in Most Aggressive Kidney inhibitor-1 (PAI-1) from conditioned media of cultured Diseases I endothelial cells. This 50-kd glycoprotein is the primary Acute/Thrombotic Diseases physiologic inhibitor of the serine proteases tissue-type and Thrombotic microangiopathy (TMA) is a pathologic lesion urokinase-type plasminogen activators (tPA and uPA, respec- that is characterized by fibrin deposition in the microvascula- tively). It now is known to mediate important biologic activities ture, often involving glomeruli and renal arterioles. TMA char- that extend far beyond fibrinolysis through interactions with its acterizes renal diseases that are caused by hemolytic uremic co-factor, vitronectin (also known as protein S), and with the syndrome, preeclampsia, scleroderma, malignant hyperten- urokinase receptor (uPAR) and its co-receptors (2,3). Plasma sion, and the antiphospholipid antibody syndrome. Glomerular PAI-1 levels increase in response to stress as an acute-phase PAI-1 deposition is a feature of TMA (10). In children who have protein. Usually present in trace amounts, plasma PAI-1 levels Escherichia coli 0157:H7 infection and later develop hemolytic uremic syndrome (11), plasma PAI-1 levels increase before the increase in several chronic inflammatory states that are associ- onset of renal disease.